Ruoxi He

741 total citations
47 papers, 548 citations indexed

About

Ruoxi He is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Ruoxi He has authored 47 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 12 papers in Epidemiology. Recurrent topics in Ruoxi He's work include Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Asthma and respiratory diseases (12 papers) and Respiratory Support and Mechanisms (5 papers). Ruoxi He is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Asthma and respiratory diseases (12 papers) and Respiratory Support and Mechanisms (5 papers). Ruoxi He collaborates with scholars based in China, United States and Australia. Ruoxi He's co-authors include Chengping Hu, Ling Qin, Yongjun Tang, Pengbo Deng, Li Huang, Jian An, Wei Yang, Bailing Luo, Chengping Hu and Xinyue Hu and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Ruoxi He

39 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruoxi He China 15 166 159 129 112 112 47 548
Weiping Hu China 13 110 0.7× 139 0.9× 47 0.4× 42 0.4× 48 0.4× 38 415
Hui-Ying Tung United States 8 100 0.6× 115 0.7× 242 1.9× 170 1.5× 18 0.2× 12 536
Bo Young Yoon South Korea 16 77 0.5× 100 0.6× 64 0.5× 90 0.8× 17 0.2× 48 595
Fumihiro Yamasawa Japan 14 84 0.5× 427 2.7× 238 1.8× 56 0.5× 50 0.4× 49 868
Liu Jl China 12 211 1.3× 51 0.3× 64 0.5× 32 0.3× 81 0.7× 55 582
Ruili He China 8 409 2.5× 40 0.3× 81 0.6× 105 0.9× 309 2.8× 11 890
Hasan Kaynar Türkiye 11 91 0.5× 116 0.7× 128 1.0× 18 0.2× 28 0.3× 33 469
Robert Słotwiński Poland 13 100 0.6× 70 0.4× 64 0.5× 82 0.7× 67 0.6× 49 516
David Schumacher Germany 15 163 1.0× 121 0.8× 51 0.4× 90 0.8× 39 0.3× 35 672

Countries citing papers authored by Ruoxi He

Since Specialization
Citations

This map shows the geographic impact of Ruoxi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoxi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoxi He more than expected).

Fields of papers citing papers by Ruoxi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruoxi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoxi He. The network helps show where Ruoxi He may publish in the future.

Co-authorship network of co-authors of Ruoxi He

This figure shows the co-authorship network connecting the top 25 collaborators of Ruoxi He. A scholar is included among the top collaborators of Ruoxi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoxi He. Ruoxi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xinyue, et al.. (2025). A new heterozygous TYK2 gene mutation: Case report and review of the literature. International Journal of Immunopathology and Pharmacology. 39. 1220571234–1220571234.
4.
Shi, Minghui, Lulu Yang, Jieping Lei, et al.. (2024). Efficacy and safety of a music-therapy facilitated pulmonary telerehabilitation program in COPD patients: the COPDMELODY study protocol. Frontiers in Medicine. 11. 1361053–1361053.
5.
He, Ruoxi, Xiaoxia Ren, Ke Huang, et al.. (2024). Developing and validating prediction models for severe exacerbations and readmissions in patients hospitalised for COPD exacerbation (SERCO) in China: a prospective observational study. BMJ Open Respiratory Research. 11(1). e001881–e001881. 1 indexed citations
6.
Deng, Yuan, Ruoxi He, Yujing Guo, et al.. (2023). Visible-light driven and efficient photoelectrochemical aptasensor constructed with N-doped carbon quantum dots-decorated TiO2 nanorods for determination of di-2-ethylhexyl phthalate. Chemical Engineering Journal. 468. 143583–143583. 29 indexed citations
7.
Hu, Chengping, et al.. (2023). MASH1 induces neuron transdifferentiation of adrenal medulla chromaffin cells.. PubMed. 48(4). 526–537.
9.
Lu, Rongli, et al.. (2023). Nebulization versus metered-dose inhaler and spacer in bronchodilator responsiveness testing: a retrospective study. Therapeutic Advances in Respiratory Disease. 17. 2683793462–2683793462. 1 indexed citations
10.
He, Ruoxi, Ye Wang, Xiaoxia Ren, et al.. (2023). Associations of medication regimen complexity with medication adherence and clinical outcomes in patients with chronic obstructive pulmonary disease: a prospective study. Therapeutic Advances in Respiratory Disease. 17. 2683785577–2683785577. 3 indexed citations
11.
Peng, Wenzhong, et al.. (2023). Safety profile differences between salbutamol and levosalbutamol: Results from the FDA Adverse Event Reporting System. Tropical Journal of Pharmaceutical Research. 22(4). 909–915.
13.
Zhang, Yan, Jun Cheng, Yuanyuan Li, et al.. (2019). The Safety and Efficacy of Anti–IL-13 Treatment with Tralokinumab (CAT-354) in Moderate to Severe Asthma: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology In Practice. 7(8). 2661–2671.e3. 14 indexed citations
14.
He, Ruoxi, Chengping Hu, & Ruichao Niu. (2019). Analysis of the Clinical Features of Tracheobronchial Fungal Infections with Tumor-Like Lesions. Respiration. 98(2). 157–164. 5 indexed citations
15.
Hu, Chengping, Rongli Lu, Ruichao Niu, et al.. (2018). Diagnostic Accuracy of Bronchodilator Response for Asthma in a Population of South China. Advances in Therapy. 35(10). 1578–1584. 2 indexed citations
16.
Tang, Yongjun, Ruoxi He, Jian An, et al.. (2017). lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP. Oncology Reports. 38(2). 941–948. 51 indexed citations
17.
Hu, Xinyue, Xiaozhao Li, Ling Qin, et al.. (2017). Respiratory Syncytial Virus Exacerbates OVA-mediated asthma in mice through C5a-C5aR regulating CD4+T cells Immune Responses. Scientific Reports. 7(1). 15207–15207. 22 indexed citations
18.
Tang, Yongjun, Ruoxi He, Jian An, et al.. (2016). The effect of H19-miR-29b interaction on bleomycin-induced mouse model of idiopathic pulmonary fibrosis. Biochemical and Biophysical Research Communications. 479(3). 417–423. 45 indexed citations
19.
Hu, Chengping, et al.. (2016). GLCCI1 Variation Is Associated with Asthma Susceptibility and Inhaled Corticosteroid Response in a Chinese Han Population. Archives of Medical Research. 47(2). 118–125. 24 indexed citations
20.
Su, Xiaoli, et al.. (2013). [Endarterium injury and the related pathway in chronic intermittent hypoxia rats].. PubMed. 38(7). 676–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026